Brahmer JR - Search Results

1

Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.

Suresh K, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, D'Alessio F, Hales RK, Lin CT, Psoter KJ, Danoff SK, Naidoo J. Suresh K, et al. Among authors: brahmer jr. J Thorac Oncol. 2018 Dec;13(12):1930-1939. doi: 10.1016/j.jtho.2018.08.2035. Epub 2018 Sep 26. J Thorac Oncol. 2018. PMID: 30267842 Free article.

2

Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questions.

Lin TL, Brahmer JR. Lin TL, et al. Among authors: brahmer jr. Curr Oncol Rep. 2004 Jul;6(4):251-8. doi: 10.1007/s11912-004-0032-3. Curr Oncol Rep. 2004. PMID: 15161575 Review.

3

Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.

Monnerat C, Le Chevalier T, Kelly K, Obasaju CK, Brahmer J, Novello S, Nakamura T, Liepa AM, Bozec L, Bunn PA Jr, Ettinger DS. Monnerat C, et al. Among authors: brahmer j. Clin Cancer Res. 2004 Aug 15;10(16):5439-46. doi: 10.1158/1078-0432.CCR-04-0218. Clin Cancer Res. 2004. PMID: 15328182 Clinical Trial.

4

Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.

Brock MV, Hooker CM, Syphard JE, Westra W, Xu L, Alberg AJ, Mason D, Baylin SB, Herman JG, Yung RC, Brahmer J, Rudin CM, Ettinger DS, Yang SC. Brock MV, et al. J Thorac Cardiovasc Surg. 2005 Jan;129(1):64-72. doi: 10.1016/j.jtcvs.2004.08.022. J Thorac Cardiovasc Surg. 2005. PMID: 15632826 Free article.

5

Adjuvant therapy for resected non-small-cell lung cancer: past, present, and future.

Juergens RA, Brahmer JR. Juergens RA, et al. Among authors: brahmer jr. Curr Oncol Rep. 2005 Jul;7(4):248-54. doi: 10.1007/s11912-005-0046-5. Curr Oncol Rep. 2005. PMID: 15946582 Review.

6

Adjuvant treatment in non-small cell lung cancer: Where are we now?

Juergens RA, Brahmer JR. Juergens RA, et al. Among authors: brahmer jr. J Natl Compr Canc Netw. 2006 Jul;4(6):595-600. doi: 10.6004/jnccn.2006.0049. J Natl Compr Canc Netw. 2006. PMID: 16813727 Review.

7

Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.

Juergens R, Brahmer J, Ettinger D. Juergens R, et al. Cancer Chemother Pharmacol. 2007 Apr;59(5):621-9. doi: 10.1007/s00280-006-0304-8. Epub 2006 Aug 26. Cancer Chemother Pharmacol. 2007. PMID: 16937106 Clinical Trial.

8

Second-line Therapy for advanced non-small-cell lung cancer.

Hann CL, Brahmer JR. Hann CL, et al. Among authors: brahmer jr. Curr Oncol Rep. 2006 Jul;8(4):243-7. doi: 10.1007/s11912-006-0027-3. Curr Oncol Rep. 2006. PMID: 17254522 Review.

9

Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.

Brahmer JR, Ettinger DS. Brahmer JR, et al. Respirology. 2007 May;12(3):320-5. doi: 10.1111/j.1440-1843.2007.01081.x. Respirology. 2007. PMID: 17539833 Review.

10

Targeting the epidermal growth factor receptor in non-small-cell lung cancer: who, which, when, and how?

Juergens R, Brahmer J. Juergens R, et al. Curr Oncol Rep. 2007 Jul;9(4):255-64. doi: 10.1007/s11912-007-0031-2. Curr Oncol Rep. 2007. PMID: 17588349 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page